| Product Code: ETC4664358 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In 2024, Israel continued to rely on a diversified range of countries for its antidiabetics import shipments, with Switzerland, UK, Belgium, USA, and Germany leading the way. The market remained highly competitive with a low concentration level, indicating a balanced distribution among suppliers. Despite a slight decline in the compound annual growth rate (CAGR) from 2020-24 at -2.14%, the market showed signs of stabilization with a marginal growth rate of -0.41% in 2024 compared to the previous year. Israel`s import market for antidiabetics remains dynamic and responsive to global trends.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antidiabetics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antidiabetics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antidiabetics Market - Industry Life Cycle |
3.4 Israel Antidiabetics Market - Porter's Five Forces |
3.5 Israel Antidiabetics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Antidiabetics Market Revenues & Volume Share, By Patient Population, 2021 & 2031F |
3.7 Israel Antidiabetics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Israel Antidiabetics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Israel |
4.2.2 Growing awareness about diabetes management and treatment |
4.2.3 Technological advancements in antidiabetic drugs and devices |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with antidiabetic medications |
4.3.3 Limited access to healthcare services in certain regions of Israel |
5 Israel Antidiabetics Market Trends |
6 Israel Antidiabetics Market Segmentations |
6.1 Israel Antidiabetics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Antidiabetics Market Revenues & Volume, By Insulin? , 2021-2031F |
6.1.3 Israel Antidiabetics Market Revenues & Volume, By Drug Class, 2021-2031F |
6.2 Israel Antidiabetics Market, By Patient Population |
6.2.1 Overview and Analysis |
6.2.2 Israel Antidiabetics Market Revenues & Volume, By Pediatric, 2021-2031F |
6.2.3 Israel Antidiabetics Market Revenues & Volume, By Adult, 2021-2031F |
6.2.4 Israel Antidiabetics Market Revenues & Volume, By Geriatric, 2021-2031F |
6.3 Israel Antidiabetics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Antidiabetics Market Revenues & Volume, By Insulin syringe/ Insulin pen, 2021-2031F |
6.3.3 Israel Antidiabetics Market Revenues & Volume, By Insulin pump, 2021-2031F |
6.3.4 Israel Antidiabetics Market Revenues & Volume, By Intravenous infusion, 2021-2031F |
6.3.5 Israel Antidiabetics Market Revenues & Volume, By Oral, 2021-2031F |
6.3.6 Israel Antidiabetics Market Revenues & Volume, By Others, 2021-2031F |
7 Israel Antidiabetics Market Import-Export Trade Statistics |
7.1 Israel Antidiabetics Market Export to Major Countries |
7.2 Israel Antidiabetics Market Imports from Major Countries |
8 Israel Antidiabetics Market Key Performance Indicators |
8.1 Percentage of diabetic population with access to antidiabetic medications |
8.2 Adoption rate of new antidiabetic technologies in Israel |
8.3 Rate of adherence to antidiabetic treatment plans among patients |
9 Israel Antidiabetics Market - Opportunity Assessment |
9.1 Israel Antidiabetics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Antidiabetics Market Opportunity Assessment, By Patient Population, 2021 & 2031F |
9.3 Israel Antidiabetics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Israel Antidiabetics Market - Competitive Landscape |
10.1 Israel Antidiabetics Market Revenue Share, By Companies, 2024 |
10.2 Israel Antidiabetics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here